- CPAP devices, designed to maintain continuous positive airway pressure for patients with obstructive sleep apnea (OSA), have become integral to respiratory care and sleep disorder management in both clinical and homecare environments due to their non-invasive nature, enhanced therapeutic outcomes, and growing user awareness
- The rising prevalence of OSA, coupled with increasing diagnosis rates and growing awareness of the health risks associated with untreated sleep apnea such as cardiovascular diseases and diabetes is the primary driver behind the escalating demand for CPAP devices.
- North America dominated the CPAP devices market with the largest revenue share of 39% in 2024, attributed to robust healthcare infrastructure, high awareness levels, favorable reimbursement policies, and the presence of key medical device manufacturers, with the U.S. leading in home-based sleep therapy adoption and telehealth-driven CPAP monitoring solutions
- Asia-Pacific is expected to be the fastest growing region in the CPAP devices market during the forecast period due to expanding healthcare access, growing sleep apnea screening initiatives, and rising healthcare expenditure
- CPAP device segment dominated the CPAP devices market with a market share of 62.8% in 2024, driven by its rising adoption for long-term obstructive sleep apnea management and continuous technological advancements improving treatment efficacy and patient comfort
